What are the treatment options for interstitial cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Interstitial Cystitis/Bladder Pain Syndrome

Treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) should follow a multi-modal approach, beginning with conservative therapies and progressing to more invasive options only when symptom control is inadequate for acceptable quality of life. 1

Diagnosis Considerations

Before initiating treatment, proper diagnosis is essential:

  • Symptoms should be present for at least 6 weeks with documented negative urine cultures
  • Cystoscopy is indicated when Hunner lesions are suspected, as they require specific treatment 1
  • Urodynamic studies are not routinely recommended but may be useful in specific cases 1

Treatment Algorithm

First-Line: Behavioral/Non-Pharmacologic Approaches

  • Self-care practices and behavioral modifications:
    • Dietary modifications: Identify and avoid bladder irritants (coffee, citrus, spicy foods)
    • Fluid management: Alter concentration/volume of urine through hydration adjustments
    • Stress management techniques to manage flare-ups (meditation, imagery)
    • Application of heat or cold over bladder or perineum
    • Pelvic floor muscle relaxation
    • Bladder training with urge suppression 1

Second-Line: Oral Medications

  • Amitriptyline (Grade B evidence): Start at low doses (10mg) and titrate gradually to 75-100mg if tolerated 1
  • Cimetidine (Grade B evidence): Shown to improve symptoms, pain, and nocturia 1
  • Hydroxyzine (Grade C evidence): May be particularly effective in patients with systemic allergies 1
  • Pentosan polysulfate (PPS) (Grade B evidence): The only FDA-approved oral medication for IC/BPS 1
    • Important safety warning: Patients should be counseled on potential risk for macular damage and vision-related injuries 1
    • Some studies show combination of oral and intravesical PPS may be more effective than oral PPS alone (46% vs 24% symptom reduction) 2

Second-Line: Intravesical Treatments

  • Dimethyl sulfoxide (DMSO) instillation:
    • FDA-approved for IC/BPS
    • Protocol: 50mL instilled directly into bladder, retained for 15 minutes, repeated every 2 weeks until maximum relief is obtained 3
    • Pre-treatment with lidocaine jelly and/or oral analgesics may reduce discomfort 3
    • Note: Patients will experience garlic-like taste and odor that may last up to 72 hours 3
  • Heparin instillation
  • Lidocaine instillation 1

Third/Fourth-Line: Procedures

  • Cystoscopy with hydrodistension (low pressure, short duration only)
  • Botulinum toxin A (100U) for patients who fail conservative therapies
    • Patients must accept possibility of needing intermittent self-catheterization
    • Not appropriate for patients who cannot tolerate catheterization 1

Last Resort: Surgical Options

  • Should only be considered after all other treatment options have been exhausted
  • May include urinary diversion with or without cystectomy 1

Treatment Pitfalls and Caveats

  1. Avoid high-pressure, long-duration hydrodistension due to risk of serious adverse events including bladder rupture 1

  2. Avoid long-term systemic glucocorticoids due to serious adverse events and known risks 1

  3. Monitor patients on pentosan polysulfate for vision changes, as it has been associated with macular damage 1

  4. Recognize treatment limitations:

    • No single treatment is effective for all patients
    • Response to treatment is unpredictable for any individual
    • Most patients benefit from combination therapies 4
    • Improvement may take time - some symptoms may continue to improve over 1-2 years of treatment 5
  5. Pain management alone is insufficient - it should be one component of a comprehensive treatment approach 1

Special Considerations

  • For patients with Hunner lesions, fulguration is appropriate at any stage of treatment 1
  • For patients with very sensitive bladders, initial intravesical treatments may need to be done under anesthesia 3
  • Treatment should be adjusted based on symptom severity and patient response

IC/BPS is a chronic condition requiring ongoing management. While there is no cure, most patients can achieve significant symptom improvement with appropriate treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.